FDA Questions J&J/Merck OTC Joint Venture's Manufacturing Practices

Johnson & Johnson and Merck attract undesired FDA attention - a letter identifying good manufacturing practice problems with the firms' OTC joint venture

More from Archive

More from Pink Sheet